losartan has been researched along with embusartan in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iouzalen, L; Marche, P; Stepien, O | 1 |
| Leenen, FH; Zhang, J | 1 |
| Leenen, FH; Tan, J; Wang, JM | 1 |
3 other study(ies) available for losartan and embusartan
| Article | Year |
|---|---|
Effects of BAY 10-6734 (Embusartan), a new angiotensin II type I receptor antagonist, on vascular smooth muscle cell growth.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Calcium; Cell Division; Cells, Cultured; Cytosol; Dihydropyridines; DNA; Imidazoles; Losartan; Male; Muscle, Smooth, Vascular; Protein Biosynthesis; Radioligand Assay; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Species Specificity; Tetrazoles | 1999 |
Peripheral administration of AT1 receptor blockers and pressor responses to central angiotensin II and sodium.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Dihydropyridines; Dose-Response Relationship, Drug; Heart Rate; Injections, Intravenous; Injections, Intraventricular; Losartan; Male; Peripheral Nervous System; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Sodium; Tetrazoles | 2001 |
Central nervous system blockade by peripheral administration of AT1 receptor blockers.
Topics: Angiotensin Receptor Antagonists; Animals; Blood-Brain Barrier; Central Nervous System; Dihydropyridines; Dose-Response Relationship, Drug; Injections, Subcutaneous; Losartan; Male; Protein Binding; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Tetrazoles | 2003 |